semaglutide dose increase Dosage Chart for Weight Loss & Dosing Guide Higher dose of semaglutide increases

SURPASS-CVOT is unique, in that it compares the dual incretin agonist with a GLP-1 RA that has been shown to have cardiovascular benefit in people with type 2 diabetes and high risk ASCVD

Why it may be effective: Together, they can reduce inflammation, speed recovery from injuries, and protect the gut and connective tissues

Treatment may be repeated at weekly intervals for a total of three treatments

While current evidence does not suggest that GPS possesses carcinogenic properties, it is imperative to conduct long-term carcinogenicity studies to thoroughly evaluate its safety profile in this context (Bampidis et al., 2023